[Complete remission of a migraine after treatment with cisplatin]. [PDF]
Guevara-Martínez E, Arjona-Padillo A.
europepmc +1 more source
Eficacia del valproato de sodio en el tratamiento profiláctico de la migraña
Introducción: La migraña es un síndrome doloroso recurrente crónico acompañado de características neurológicas, objetivos: evaluar la eficacia del valproato de sodio en la profilaxis de la migraña a través de cambios en intensidad, dolor y frecuencia ...
Juan Fernando Lizárraga Luyo +2 more
doaj
[Cardiovascular safety of new drugs for the acute and preventive treatment of migraine: gepants and ditans]. [PDF]
Pérez-Rodríguez A +6 more
europepmc +1 more source
Primary headache with onset in childhood and adolescence: natural history and prognostic factors in a Portuguese population. [PDF]
da Silva Cardoso J +5 more
europepmc +1 more source
Non-responder migraine patients to a first anti-CGRP monoclonal antibody benefit from a switch to a second one. [PDF]
Fresán-Restituto D +3 more
europepmc +1 more source
[Episodic ataxia type 2: a clinical, genetic and radiological study of 10 patients]. [PDF]
Alcalá-Torres J +4 more
europepmc +1 more source
Introducción: La migraña es la cefalea primaria de mayor impacto en la población general; de acuerdo con la información local se calcula que al menos 3 millones de personas en Colombia padecen esta condición, conduciendo esta entidad a alta carga y ...
Joe Muñoz +12 more
doaj
[Failure of an anti-CGRP monoclonal antibody in the treatment of migraine. Is it worthwhile trying another one?] [PDF]
López-Moreno Y +3 more
europepmc +1 more source
[Comparison of tiapride and topiramate in the prophylactic treatment of chronic migraine: a randomised, double-blind, pilot study]. [PDF]
Juica-Avello S +10 more
europepmc +1 more source
Comorbidity between hypothyroidism and headache disorders in a Mexican population. [PDF]
Fernández-Garza LE, Marfil A.
europepmc +1 more source

